Rocket Doctor AI joins forces with the CAN Health Network to deliver an AI-powered Clinical Decision Support System (CDSS) in collaboration with Health Cities Alberta.Initial rollout will take place at up to four primary care sites serving up to 20 physicians, running from December 2025 to March 2026.The project aims to reduce intake time by 25–40% and improve diagnostic accuracy using Rocket Doctor AI’s proprietary Global Library of Medicine (GLM). Goal to eventually expand CDSS province-wide across Albert ...

Company Leadership Change - Christopher Cherry will assume the role of Interim Chief Financial Officer, replacing David Worner, effective December 8, 2025 [1] - The company expresses gratitude to Mr. Worner for his contributions and wishes him well in future endeavors [1] Stock Options and Restricted Share Units - The company has granted a total of 579,028 stock options, exercisable at $0.84 per share, valid for a term of three to five years [2] - Additionally, 931,112 restricted share units have been issued, valid for a term between two to five years, to executive officers, directors, and consultants [2] - These stock options and restricted share units are part of the company's share compensation plans and are subject to vesting conditions [2] Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions aimed at improving access to high-quality healthcare throughout the patient journey [3] - The company's technology includes the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from numerous physicians globally [3] Digital Health Platform - Rocket Doctor Inc. operates an AI-powered digital health platform and marketplace, enabling over 300 MDs to provide care for more than 700,000 patient visits [4] - The technology allows doctors to independently launch and manage virtual or hybrid in-person practices, enhancing efficiency and patient access [4] Commitment to Underserved Communities - The company aims to reduce administrative burdens and improve physician-patient interactions, particularly in underserved, rural, and remote communities in Canada [5] - It also supports patients on Medicaid and Medicare in the United States, focusing on making healthcare more scalable, equitable, and patient-centered [5]

Rocket Doctor and Toronto Metropolitan University (TMU) have formed a strategic partnership to leverage the independent physicians on the Rocket Doctor platform to expand clinical education opportunities across TMU’s Medical School.Both organizations will collaborate on joint communications and create streamlined pathways for physicians on Rocket Doctor to engage with TMU and apply for clinical faculty roles.Rocket Doctor will promote and facilitate clinical faculty appointments, verify physician status, su ...

Continued organic quarter over quarter revenue growth despite expected summer seasonalityEarnings per share for Q3, 2025: ($0.05) per share.Oversubscribed raise of C$4.23m contributing to significantly improved cash position.Announced signed in-network contracts and credentialing with several major U.S. insurance companies. Extending Rocket Doctor’s U.S. total in-network reach to over 13 million members. Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment ...

Core Insights - Rocket Doctor AI Inc. participated in the Google Accelerator Alumni Summit, where CEO Dr. Bill Cherniak shared insights on the company's journey and the deployment of AI in healthcare [1][2][7] - The company is leveraging Google's Gemini models for its AI Nurse platform and is exploring new opportunities following the launch of Gemini 3.0 [3][7] - Rocket Doctor AI aims to enhance access to healthcare through its digital health platform, which supports physician autonomy and patient care coordination [4][10] Company Developments - Dr. Cherniak's participation in the summit included discussions with senior leaders from Google DeepMind and engineering teams, focusing on product planning and next-generation capabilities [2][5] - The company has graduated from the Heal.LA Accelerator program, showcasing innovative approaches to increase healthcare access for millions [4][7] - Rocket Doctor AI's technology has empowered over 300 MDs to manage more than 700,000 patient visits, improving efficiency and expanding patient access [9][10] Future Outlook - The launch of Gemini 3.0 is seen as a pivotal moment for accelerating clinical innovation within Rocket Doctor AI [6] - The company is committed to developing patient-centered, clinically sound AI solutions, with plans to strengthen access to care as part of its innovation roadmap into 2026 [6][10] - Rocket Doctor AI's proprietary Global Library of Medicine (GLM) is a key component of its technology, developed with input from numerous physicians worldwide [8][10]

Core Insights - Rocket Doctor AI Inc. has entered into a definitive share purchase agreement to acquire 100% of Alea Health Holdings Ltd., enhancing its position in the AI-driven healthtech sector, particularly in mental health [1][2][3] Acquisition Details - The acquisition involves a cash payment of US $15,000 and the issuance of 285,712 common shares valued at CAD $0.70 each, along with the assumption of Alea's SAFE Note obligations totaling US $180,000 [6][7] - The transaction is subject to various closing conditions, including employment agreements with key Alea employees and necessary regulatory approvals [7] Strategic Benefits - The acquisition allows Rocket Doctor AI to leverage Alea's advanced online therapy platform, which utilizes conversational AI and voice technology for improved patient engagement and support [2][4] - It provides an opportunity to expand into the Middle East, particularly the UAE, where significant investments in AI-driven healthcare are planned, thus enhancing Rocket Doctor AI's market presence [3][5] Team and Expertise - Alea's leadership team brings over 30 years of combined experience in AI, machine learning, and healthcare, which will strengthen Rocket Doctor AI's capabilities in delivering innovative health solutions [4][5] Market Positioning - The integration of Alea's platform with Rocket Doctor AI's Global Library of Medicine aims to create a comprehensive healthcare solution, addressing the growing demand for personalized, AI-driven care [2][5]

Core Insights - Rocket Doctor AI Inc. has granted a total of 831,356 restricted share units (RSUs) and 20,964 stock options to its consultants and employees [1][2] - The stock options are exercisable at C$0.82 per share for three years, with specific vesting provisions [2] - The company aims to enhance healthcare accessibility through its AI-powered solutions, particularly targeting underserved communities [5] Company Overview - Rocket Doctor AI Inc. provides AI-driven healthcare solutions designed to improve patient care throughout the healthcare journey [3] - The company operates the Global Library of Medicine (GLM), a decision support system developed with input from numerous physicians globally [3] - Rocket Doctor Inc. supports over 300 MDs in managing virtual or hybrid practices, facilitating over 700,000 patient visits [4] Technology and Impact - The technology reduces administrative burdens, allowing for more meaningful interactions between physicians and patients [5] - The company focuses on reaching rural and remote communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [5] - Rocket Doctor AI utilizes advanced AI, large language models, and connected medical devices to redefine modern healthcare [5]

Core Insights - Rocket Doctor AI Inc. has appointed four senior professionals to its leadership team to accelerate growth and enhance clinical operations, particularly in the U.S. market [1][8] - The new leadership will focus on expanding Rocket Doctor's digital health platform and marketplace, strengthening partnerships, and advancing coast-to-coast expansion in the United States [1][6] Leadership Appointments - Dr. Evan Ou has been appointed as U.S. Medical Director, bringing extensive experience in emergency medicine and virtual care [2] - Dr. Sudha Kumar joins as U.S. MD Lead for Psychiatry, with a strong background in behavioral health and integrated care [3] - Dr. Mike Solemar has been appointed California MD Lead, tasked with expanding the physician network and supporting partnerships with Medicaid managed care organizations [4] - Jimmy Vannavong joins as Director of Growth, focusing on scaling technology ventures and leading Rocket Doctor's growth strategy through data-driven marketing [5] Strategic Goals - The expansion of the U.S. leadership team is aimed at reinforcing operational and clinical foundations to better serve patients and physicians while creating new growth opportunities [6][7] - The company aims to make high-quality care more affordable and accessible for millions of Americans, particularly in rural and underserved communities [7][8] Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance patient access throughout the healthcare journey [10][11] - The company has empowered over 300 MDs to manage more than 700,000 patient visits, improving efficiency and expanding access to care [11][12] - The technology aims to reduce administrative burdens and enhance physician-patient interactions, focusing on underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [12]

Core Insights - Rocket Doctor AI Inc. has engaged Fundamental Research Corp. (FRC) for analyst coverage, which will include a full financial analysis and independent analyst rating [1][3] - FRC is a prominent independent research firm with a 22-year history of covering over 750 companies, recognized for its high-quality research [2] - The engagement with FRC includes one initiating report and updates over an 18-month period, with a fee of CAD$35,000 paid by Rocket Doctor AI [3] Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, utilizing a clinically validated decision support system known as the Global Library of Medicine (GLM) [4][6] - The company has empowered over 300 medical doctors to manage more than 700,000 patient visits through its digital health platform, improving efficiency and expanding patient access [5] - The technology aims to reduce administrative burdens, allowing for more meaningful interactions between physicians and patients, particularly targeting underserved communities in Canada and supporting patients on Medicaid and Medicare in the U.S. [6]

Core Insights - Rocket Doctor AI Inc. has engaged Fundamental Research Corp. (FRC) for analyst coverage, aiming to enhance its visibility and credibility in the market [1][3] - FRC is a well-established independent research firm with a 22-year history, covering over 750 companies and recognized for its high-quality research [2] - The agreement includes a comprehensive financial analysis, an Independent Analyst Rating, and ongoing updates over an 18-month period, with a fee of CAD$35,000 paid to FRC [3] Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to improve access to quality healthcare throughout the patient journey [4] - The company’s technology includes the Global Library of Medicine (GLM), a decision support system developed with input from numerous physicians globally [4] - Rocket Doctor AI has empowered over 300 MDs to manage more than 700,000 patient visits, facilitating the launch of virtual or hybrid practices [5] Technology and Impact - The technology reduces administrative burdens, allowing for more meaningful interactions between physicians and patients [6] - The company focuses on underserved, rural, and remote communities in Canada, as well as supporting Medicaid and Medicare patients in the U.S. [6] - By leveraging advanced AI and connected medical devices, Rocket Doctor AI aims to redefine modern healthcare, making it more scalable and equitable [6]